DEPARTMENTS | DIRECTORY | ADVANCED SEARCH | SCHOOL HOME
School Home NYU School of Medicine

irb
 Today is Saturday, September 6th 2008
 
Guidance Documents
Decision Charts -
Human Subject Regulations Decision Charts
NYU SoM IRB Guidelines for Writing a Research Protocol
Guidance of Required Elements of a Protocol
Guidance on Determining Human Subjects Research
Guidance on Submitting a New Application
Guidance on Using an FDA Regulated Product
Guidance for the Investigator as a Sponsor
Guidance for Data Monitoring Plans
Guidance for Emergency Use of an IND
Guidance for Emergency Use of an IND-IDE
Guidelines for Research in Pregnant Women, Human Fetuses and Neonates
Guidance on Research with Prisoners
Guidelines for Involving Children in Research
Guidance for Cognitively Impaired
Guidance for Students and Employees in Research
Guidelines for Recruitment of Research Subjects
Guidelines for Advertisements for Research Subjects
Guidance on Genetic Research
Guidelines on Protocol Development for Genetic Research
Guidance on the Consent Process and Documentation
Guidelines of Requests for Waiver of Consent
Guidance on Assent of A Minor
Guidance for Non-English Speaking Subjects
Guidance on Verbal Consent
Guidance on Waiver of Parental Permission
Guidelines for Amending a Protocol
Guidance on Continuing Review and Final Closures
Essential Documents
Guidelines to Investigator Responsibilities
Letter for Sponsors - Reportable Events Policy
Guidance for Reportable Events and Reporting Unanticipated Problems
Reviews Preparatory to Research

Research Data Compilations

How many copies do I submit?
 

Guidance on Required Elements of a Protocol

You can also download this page in PDF |MS Word format.

Basic IRB Findings
Federal regulations require the IRB review certain elements when making determination on studies involving human subjects even the study is minimal risk. The IRB must find the elements in each protocol considered by the IRB as an approvable protocol. The protocol must include detailed justification on the following eight elements:

1. Risks to subjects are minimized by using sound research design and not expose subjects to unnecessary risks.
2. Risk are reasonable in relation to anticipated benefit - therefore the protocol must include a list of risk and benefits.
3. Selection of subjects is equitable. The protocol should cover:
-Number of subjects.
-Gender of Subjects.
-Age of Subjects.
-Racial and Ethnic Origin.
-Inclusion Criteria/exclusion Criteria.
-Vulnerable Subjects.
4. How informed consent will be sought form each participant
-Method of Subject Identification and Recruitment.
-Process of Consent.
-Costs to the Subject.
-Payment for Participation.
5. Documentation of Consent
6. Monitoring of data to ensure safety - when appropriate
7. Provisions to protect privacy and confidentiality of subjects
8. If any subjects will be vulnerable to coercion - how the subjects will be protected.

For details regarding how to draft a protocol see the IRB's Basic Guidelines for Research Protocols.


 

IRB Resources
HRPP Accreditation Tutorial
IRB CITI Tutorials
Decision Charts -
Human Subject Regulations Decision Charts
IRB Newsletter
IRB Course Calendar
Policies and Procedures
HELP Downloading Forms
Lay Glossary
Useful Web Links
Sponsored Programs Administration (SPA)
Office of Clinical Trials (OCT)
Email a Suggestion or Comment to the IRB
Contact the IRB
GCRC Web Page
Instructions for Research Conducted at Bellevue
Printer-Friendly Version
Email this to a friend


Dept. Home | FAQs | IRB Forms | HIPAA Forms | Other Forms | Consent Templates | Info Sheets | Tool Kit | Schedule | Categories of Review | Policies | Glossary | Helpful Web Links | FWA | Contact